LTX-315 T6881
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
LTX-315, the oncolytic peptide, inhibits cancer cells through Bax/Bak-regulated mitochondrial membrane permeabilization.
CAS nr:
1345407-05-7
Purity:
98%
Molecular Weight:
1439,79
SMILES:
NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2c1cccc2)C(=O)N[C@@H](Cc1c[nH]c2c1cccc2)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2c1cccc2)C(=O)N[C@@H](C(c1ccccc1)c1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N
Formula:
C78H106N18O9
Pathway:
Apoptosis
Target:
BCL
